MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$26,184K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from common stock and p...
Maturity of investments
Net loss
Others
Negative Cash Flow Breakdown
Purchase of investments
Change in fair value of warrant ...
Payment of offering costs
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
7,397
-21,299
12,258
-8,591
Stock-based compensation expense
568
580
687
526
Accretion of investments discount
67
41
62
98
Amortization of debt issuance costs and discount
0
0
0
0
Change in fair value of warrant liabilities
-14,152
5,249
-1,319
640
Change in fair value of derivative liability
-
-
0
0
Noncash operating lease expense for right-of-use asset
95
91
87
83
Offering costs for march 2026 private placement warrant issuance
136
755
-
-
Prepaid expenses, other current assets, deferred costs, and other
694
816
-421
-942
License agreement receivable
0
0
-10,000
0
License agreement contract asset
0
-
0
0
Accounts payable
-472
906
-1,242
-2,705
Accrued expenses
655
-1,412
17
297
Asset purchase agreement payable
-
8,000
-
-
Deferred revenue
-235
-
-2,337
287
Other liabilities
-116
-114
-109
-105
Net cash used in operating activities
-14,885
-8,101
18,401
-8,724
Purchase of investments
36,213
3,275
18,903
0
Maturity of investments
11,455
2,750
7,079
12,417
Net cash (used in) provided by investing activities
-24,758
-525
-11,824
12,417
Proceeds from common stock and prefunded warrants from march 2026 private placement (note 12)
-
24,020
-
-
Proceeds from common stock issued
-
-
1
4
Proceeds from common stock issued for restricted stock units
-
1
-
-
Proceeds from common stock and pre-funded warrants issued for march 2026 private placement (note 12)
40,019
-
-
-
Payment of convertible debt
0
0
0
0
Payment of deferred offering costs
-
-
-
0
Payment of offering costs
2,539
0
226
-
Proceeds from employee stock purchase plan issuances
0
17
0
25
Net cash provided by (used in) financing activities
13,459
24,038
-115
29
Net decrease in cash, cash equivalents, and restricted cash
-26,184
15,412
6,462
3,722
Cash, cash equivalents, and restricted cash at beginning of period
36,860
21,448
14,986
16,595
Cash, cash equivalents, and restricted cash at end of period
10,676
36,860
21,448
14,986
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from common
stock and pre-funded...
$40,019K
Net cash provided by
(used in) financing...
$13,459K
(195.56%↑ Y/Y)
Canceled cashflow
$26,560K
Net decrease in
cash, cash...
-$26,184K
(-391.16%↓ Y/Y)
Canceled cashflow
$13,459K
Maturity of investments
$11,455K
(-51.69%↓ Y/Y)
Net loss
$7,397K
(160.26%↑ Y/Y)
Accrued expenses
$655K
(149.77%↑ Y/Y)
Stock-based compensation
expense
$568K
(-65.34%↓ Y/Y)
Offering costs for march
2026 private...
$136K
Noncash operating lease
expense for...
$95K
(-39.10%↓ Y/Y)
something is missing
-$24,021K
Payment of offering
costs
$2,539K
Net cash (used in)
provided by investing...
-$24,758K
(-204.41%↓ Y/Y)
Net cash used in
operating activities
-$14,885K
(0.50%↑ Y/Y)
Canceled cashflow
$11,455K
Canceled cashflow
$8,851K
Purchase of investments
$36,213K
Change in fair value of
warrant liabilities
-$14,152K
(-177.82%↓ Y/Y)
something is missing
-$8,000K
Prepaid expenses, other
current assets,...
$694K
(186.43%↑ Y/Y)
Accounts payable
-$472K
(-127.55%↓ Y/Y)
Deferred revenue
-$235K
(63.96%↑ Y/Y)
Other liabilities
-$116K
(39.90%↑ Y/Y)
Accretion of investments
discount
$67K
(-78.66%↓ Y/Y)
Buy us a coffee
SCYNEXIS INC (SCYX)
SCYNEXIS INC (SCYX)